Trial Outcomes & Findings for MiACLR: Michigan Initiative for Anterior Cruciate Ligament Rehabilitation (NCT NCT03626857)

NCT ID: NCT03626857

Last Updated: 2026-01-02

Results Overview

Bilateral concentric isokinetic muscle strength at 60 degrees per second. Limb symmetry index is calculated as (ACL strength/Non-ACL strength)\*100

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

135 participants

Primary outcome timeframe

Post-NMES+ECC intervention (approximately 16 weeks post-ACL reconstruction)

Results posted on

2026-01-02

Participant Flow

Participants were recruited beginning in January of 2019 through July of 2023 from Michigan Medicine.

Participants were not randomized after enrollment for the following reasons: 1. Withdrew Consent 2. Screen fail 3. COVID drops (COVID pandemic prevented testing) 4. Lost to follow-up A baseline testing session occurred prior to randomization.

Participant milestones

Participant milestones
Measure
Active High-Intensity NMES+ECC
Neuromuscular electrical stimulation (NMES) and Eccentric Exercise (ECC). Patients randomized to the NMES+ECC group will first receive high-intensity NMES for 2x/week for 8 weeks, beginning at the first post-operative visit. Beginning approximately 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive eccentric exercise 2x/week for an additional 8 weeks. For NMES, patients will have electrical stimulation delivered to their quadriceps. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For eccentric exercise, patients will train for 4 sets of 10 repetitions. This group will also receive standard of care ACL rehabilitation alongside the study interventions.
Placebo Low-Intensity NMES + ECC
Neuromuscular electrical stimulation (NMES) low intensity/placebo + Eccentric Exercise (ECC) low intensity/placebo arm. Patients randomized to the NMES low intesntiy/placebo + ECC low intensity/placebo group will first receive NMES placebo/low-intensity treatment for 2x/week for 8 weeks, beginning at the first post-operative physical therapy visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive an eccentric exercise low-intensity/placebo 2x/week for 8 weeks. For the NMES low intensity/placebo, patients will have it delivered to their quadriceps 2x/week for 8 weeks beginning at the first post-operative visit. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For the eccentric exercise low-intensity/placebo, patients will begin to receive low dose eccentric exercise two times per week for 8 weeks. Patients will train for 4 sets of 10 repetitions.
Overall Study
STARTED
57
56
Overall Study
Post-NMES Intervention Testing
53
53
Overall Study
Post-ECC Intervention Testing
52
50
Overall Study
9 month post-ACLR testing
49
44
Overall Study
18 month post-ACLR testing
37
36
Overall Study
COMPLETED
37
36
Overall Study
NOT COMPLETED
20
20

Reasons for withdrawal

Reasons for withdrawal
Measure
Active High-Intensity NMES+ECC
Neuromuscular electrical stimulation (NMES) and Eccentric Exercise (ECC). Patients randomized to the NMES+ECC group will first receive high-intensity NMES for 2x/week for 8 weeks, beginning at the first post-operative visit. Beginning approximately 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive eccentric exercise 2x/week for an additional 8 weeks. For NMES, patients will have electrical stimulation delivered to their quadriceps. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For eccentric exercise, patients will train for 4 sets of 10 repetitions. This group will also receive standard of care ACL rehabilitation alongside the study interventions.
Placebo Low-Intensity NMES + ECC
Neuromuscular electrical stimulation (NMES) low intensity/placebo + Eccentric Exercise (ECC) low intensity/placebo arm. Patients randomized to the NMES low intesntiy/placebo + ECC low intensity/placebo group will first receive NMES placebo/low-intensity treatment for 2x/week for 8 weeks, beginning at the first post-operative physical therapy visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive an eccentric exercise low-intensity/placebo 2x/week for 8 weeks. For the NMES low intensity/placebo, patients will have it delivered to their quadriceps 2x/week for 8 weeks beginning at the first post-operative visit. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For the eccentric exercise low-intensity/placebo, patients will begin to receive low dose eccentric exercise two times per week for 8 weeks. Patients will train for 4 sets of 10 repetitions.
Overall Study
Adverse Event
9
7
Overall Study
Lost to Follow-up
8
8
Overall Study
Withdrawal by Subject
2
2
Overall Study
Protocol Violation
1
3

Baseline Characteristics

MiACLR: Michigan Initiative for Anterior Cruciate Ligament Rehabilitation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
NMES+ECC
n=57 Participants
Neuromuscular electrical stimulation (NMES) and Eccentric Exercise (ECC). Patients randomized to the NMES+ECC group will first receive NMES for 2x/week for 8 weeks, beginning at the first post-operative visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive eccentric exercise 2x/week for an additional 8 weeks. For NMES, patients will have electrical stimulation delivered to their quadriceps. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For eccentric exercise, patients will train for 4 sets of 10 repetitions. This group will also receive standard of care ACL rehabilitation alongside the study interventions.
NMES Placebo + ECC Placebo
n=56 Participants
Neuromuscular electrical stimulation (NMES) low intensity/placebo + Eccentric Exercise (ECC) low intensity/placebo arm. Patients randomized to the NMES low intesntiy/placebo + ECC low intensity/placebo group will first receive NMES placebo/low-intensity treatment for 2x/week for 8 weeks, beginning at the first post-operative physical therapy visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive an eccentric exercise low-intensity/placebo 2x/week for 8 weeks. For the NMES low intensity/placebo, patients will have it delivered to their quadriceps 2x/week for 8 weeks beginning at the first post-operative visit. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For the eccentric exercise low-intensity/placebo, patients will begin to receive eccentric exercise two times per week for 8 weeks. Patients will train for 4 sets of 10 repetitions.
Total
n=113 Participants
Total of all reporting groups
Age, Continuous
22.9 years
STANDARD_DEVIATION 7.1 • n=228 Participants
23.0 years
STANDARD_DEVIATION 8.1 • n=115 Participants
22.9 years
STANDARD_DEVIATION 7.6 • n=343 Participants
Sex: Female, Male
Female
26 Participants
n=228 Participants
26 Participants
n=115 Participants
52 Participants
n=343 Participants
Sex: Female, Male
Male
31 Participants
n=228 Participants
30 Participants
n=115 Participants
61 Participants
n=343 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=228 Participants
0 Participants
n=115 Participants
0 Participants
n=343 Participants
Race (NIH/OMB)
Asian
8 Participants
n=228 Participants
8 Participants
n=115 Participants
16 Participants
n=343 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=228 Participants
0 Participants
n=115 Participants
0 Participants
n=343 Participants
Race (NIH/OMB)
Black or African American
7 Participants
n=228 Participants
10 Participants
n=115 Participants
17 Participants
n=343 Participants
Race (NIH/OMB)
White
40 Participants
n=228 Participants
36 Participants
n=115 Participants
76 Participants
n=343 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=228 Participants
1 Participants
n=115 Participants
2 Participants
n=343 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=228 Participants
1 Participants
n=115 Participants
2 Participants
n=343 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=228 Participants
3 Participants
n=115 Participants
5 Participants
n=343 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
54 Participants
n=228 Participants
51 Participants
n=115 Participants
105 Participants
n=343 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=228 Participants
2 Participants
n=115 Participants
3 Participants
n=343 Participants

PRIMARY outcome

Timeframe: Post-NMES+ECC intervention (approximately 16 weeks post-ACL reconstruction)

Population: Active High-Intensity NMES + ECC: 2 subjects withdrawn by investigator, 0 subjects lost to follow up, 1 subject withdrew consent, 2 people missing strength data Placebo Low-Intensity NMES + ECC: 1 subjects withdrawn by investigator, 2 subjects lost to follow up, 2 subject withdrew consent, 1 person missing strength data

Bilateral concentric isokinetic muscle strength at 60 degrees per second. Limb symmetry index is calculated as (ACL strength/Non-ACL strength)\*100

Outcome measures

Outcome measures
Measure
NMES+ECC
n=52 Participants
Neuromuscular electrical stimulation (NMES) and Eccentric Exercise (ECC). Patients randomized to the NMES+ECC group will first receive NMES for 2x/week for 8 weeks, beginning at the first post-operative visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive eccentric exercise 2x/week for an additional 8 weeks. For NMES, patients will have electrical stimulation delivered to their quadriceps. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For eccentric exercise, patients will train for 4 sets of 10 repetitions. This group will also receive standard of care ACL rehabilitation alongside the study interventions.
NMES placebo + ECC placebo
n=50 Participants
Neuromuscular electrical stimulation (NMES) low intensity/placebo + Eccentric Exercise (ECC) low intensity/placebo arm. Patients randomized to the NMES low intesntiy/placebo + ECC low intensity/placebo group will first receive NMES placebo/low-intensity treatment for 2x/week for 8 weeks, beginning at the first post-operative physical therapy visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive an eccentric exercise low-intensity/placebo 2x/week for 8 weeks. For the NMES low intensity/placebo, patients will have it delivered to their quadriceps 2x/week for 8 weeks beginning at the first post-operative visit. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For the eccentric exercise low-intensity/placebo, patients will begin to receive eccentric exercise two times per week for 8 weeks. Patients will train for 4 sets of 10 repetitions.
Immediately Post NMES+ECC Intervention Isokinetic Quadriceps Strength Index
60.9 Percentage
Standard Deviation 20.5
58.4 Percentage
Standard Deviation 19.2

PRIMARY outcome

Timeframe: 9 months (9 months post-ACL reconstruction)

Population: Active High-Intensity NMES + ECC: 3 subjects withdrawn by investigator, 4 subjects lost to follow up, 1 subject withdrew consent Placebo Low-Intensity NMES + ECC: 4 subjects withdrawn by investigator, 6 subjects lost to follow up, 2 subject withdrew consent

Bilateral concentric isokinetic muscle strength at 60 degrees per second. Limb symmetry index is calculated as (ACL strength/Non-ACL strength)\*100

Outcome measures

Outcome measures
Measure
NMES+ECC
n=49 Participants
Neuromuscular electrical stimulation (NMES) and Eccentric Exercise (ECC). Patients randomized to the NMES+ECC group will first receive NMES for 2x/week for 8 weeks, beginning at the first post-operative visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive eccentric exercise 2x/week for an additional 8 weeks. For NMES, patients will have electrical stimulation delivered to their quadriceps. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For eccentric exercise, patients will train for 4 sets of 10 repetitions. This group will also receive standard of care ACL rehabilitation alongside the study interventions.
NMES placebo + ECC placebo
n=44 Participants
Neuromuscular electrical stimulation (NMES) low intensity/placebo + Eccentric Exercise (ECC) low intensity/placebo arm. Patients randomized to the NMES low intesntiy/placebo + ECC low intensity/placebo group will first receive NMES placebo/low-intensity treatment for 2x/week for 8 weeks, beginning at the first post-operative physical therapy visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive an eccentric exercise low-intensity/placebo 2x/week for 8 weeks. For the NMES low intensity/placebo, patients will have it delivered to their quadriceps 2x/week for 8 weeks beginning at the first post-operative visit. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For the eccentric exercise low-intensity/placebo, patients will begin to receive eccentric exercise two times per week for 8 weeks. Patients will train for 4 sets of 10 repetitions.
9 Months Isokinetic Quadriceps Strength Limb Symmetry Index
76.8 Percentage
Standard Deviation 18.0
74.5 Percentage
Standard Deviation 19.6

SECONDARY outcome

Timeframe: 9 months post-ACL reconstruction

Population: Active High-Intensity NMES + ECC : 3 subjects withdrawn by investigator, 4 subjects lost to follow up, 1 subject withdrew consent, 16 subjects could not complete a single leg hop so data is missing Placebo Low-Intensity NMES + ECC: 4 subjects withdrawn by investigator, 6 subjects lost to follow up, 2 subject withdrew consent, 10 subjects could not complete a single leg hop so data is missing

Peak knee flexion angle of the ACL leg recorded during a single-legged hop (units: degrees)

Outcome measures

Outcome measures
Measure
NMES+ECC
n=33 Participants
Neuromuscular electrical stimulation (NMES) and Eccentric Exercise (ECC). Patients randomized to the NMES+ECC group will first receive NMES for 2x/week for 8 weeks, beginning at the first post-operative visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive eccentric exercise 2x/week for an additional 8 weeks. For NMES, patients will have electrical stimulation delivered to their quadriceps. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For eccentric exercise, patients will train for 4 sets of 10 repetitions. This group will also receive standard of care ACL rehabilitation alongside the study interventions.
NMES placebo + ECC placebo
n=34 Participants
Neuromuscular electrical stimulation (NMES) low intensity/placebo + Eccentric Exercise (ECC) low intensity/placebo arm. Patients randomized to the NMES low intesntiy/placebo + ECC low intensity/placebo group will first receive NMES placebo/low-intensity treatment for 2x/week for 8 weeks, beginning at the first post-operative physical therapy visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive an eccentric exercise low-intensity/placebo 2x/week for 8 weeks. For the NMES low intensity/placebo, patients will have it delivered to their quadriceps 2x/week for 8 weeks beginning at the first post-operative visit. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For the eccentric exercise low-intensity/placebo, patients will begin to receive eccentric exercise two times per week for 8 weeks. Patients will train for 4 sets of 10 repetitions.
Knee Flexion Angle at 9 Months
50.9 Degrees
Standard Deviation 14.4
44.4 Degrees
Standard Deviation 12.9

SECONDARY outcome

Timeframe: 9 months post-ACL reconstruction

Population: Active High-Intensity NMES + ECC: 3 subjects withdrawn by investigator, 4 subjects lost to follow up, 1 subject withdrew consent, 16 subjects could not complete a single leg hop so data is missing Placebo Low-Intensity NMES + ECC: 4 subjects withdrawn by investigator, 6 subjects lost to follow up, 2 subject withdrew consent, 10 subjects could not complete a single leg hop so data is missing

Peak knee flexion moment recorded during a single-legged hop (units: Nm/kg\*m)

Outcome measures

Outcome measures
Measure
NMES+ECC
n=33 Participants
Neuromuscular electrical stimulation (NMES) and Eccentric Exercise (ECC). Patients randomized to the NMES+ECC group will first receive NMES for 2x/week for 8 weeks, beginning at the first post-operative visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive eccentric exercise 2x/week for an additional 8 weeks. For NMES, patients will have electrical stimulation delivered to their quadriceps. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For eccentric exercise, patients will train for 4 sets of 10 repetitions. This group will also receive standard of care ACL rehabilitation alongside the study interventions.
NMES placebo + ECC placebo
n=34 Participants
Neuromuscular electrical stimulation (NMES) low intensity/placebo + Eccentric Exercise (ECC) low intensity/placebo arm. Patients randomized to the NMES low intesntiy/placebo + ECC low intensity/placebo group will first receive NMES placebo/low-intensity treatment for 2x/week for 8 weeks, beginning at the first post-operative physical therapy visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive an eccentric exercise low-intensity/placebo 2x/week for 8 weeks. For the NMES low intensity/placebo, patients will have it delivered to their quadriceps 2x/week for 8 weeks beginning at the first post-operative visit. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For the eccentric exercise low-intensity/placebo, patients will begin to receive eccentric exercise two times per week for 8 weeks. Patients will train for 4 sets of 10 repetitions.
Knee Flexion Moment at 9 Months
1.4 Nm/kg*m
Standard Deviation 0.3
1.3 Nm/kg*m
Standard Deviation 0.3

SECONDARY outcome

Timeframe: 18 months post-ACL reconstruction

Population: Active High-Intensity NMES + ECC: 10 subjects withdrawn by investigator, 8 subjects lost to follow up, 2 subjects withdrew consent, 7 subjects could not complete a single leg hop so data is missing Placebo Low-Intensity NMES + ECC: 7 subjects withdrawn by investigator, 10 subjects lost to follow up, 2 subjects withdrew consent, 6 subjects could not complete a single leg hop so data is missing

Peak knee flexion angle recorded during a single-legged hop (units: degrees)

Outcome measures

Outcome measures
Measure
NMES+ECC
n=30 Participants
Neuromuscular electrical stimulation (NMES) and Eccentric Exercise (ECC). Patients randomized to the NMES+ECC group will first receive NMES for 2x/week for 8 weeks, beginning at the first post-operative visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive eccentric exercise 2x/week for an additional 8 weeks. For NMES, patients will have electrical stimulation delivered to their quadriceps. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For eccentric exercise, patients will train for 4 sets of 10 repetitions. This group will also receive standard of care ACL rehabilitation alongside the study interventions.
NMES placebo + ECC placebo
n=31 Participants
Neuromuscular electrical stimulation (NMES) low intensity/placebo + Eccentric Exercise (ECC) low intensity/placebo arm. Patients randomized to the NMES low intesntiy/placebo + ECC low intensity/placebo group will first receive NMES placebo/low-intensity treatment for 2x/week for 8 weeks, beginning at the first post-operative physical therapy visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive an eccentric exercise low-intensity/placebo 2x/week for 8 weeks. For the NMES low intensity/placebo, patients will have it delivered to their quadriceps 2x/week for 8 weeks beginning at the first post-operative visit. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For the eccentric exercise low-intensity/placebo, patients will begin to receive eccentric exercise two times per week for 8 weeks. Patients will train for 4 sets of 10 repetitions.
Knee Flexion Angle at 18 Months
53.4 Degrees
Standard Deviation 14.7
48.8 Degrees
Standard Deviation 11.4

SECONDARY outcome

Timeframe: 18 months post-ACL reconstruction

Population: Active High-Intensity NMES + ECC: 10 subjects withdrawn by investigator, 8 subjects lost to follow up, 2 subject withdrew consent, 7 subjects could not complete a single leg hop so data is missing Placebo Low-Intensity NMES + ECC: 7 subjects withdrawn by investigator, 10 subjects lost to follow up, 2 subject withdrew consent, 6 subjects could not complete a single leg hop so data is missing

Peak knee flexion moment recorded during a single-legged hop (units: Nm/kg\*m)

Outcome measures

Outcome measures
Measure
NMES+ECC
n=30 Participants
Neuromuscular electrical stimulation (NMES) and Eccentric Exercise (ECC). Patients randomized to the NMES+ECC group will first receive NMES for 2x/week for 8 weeks, beginning at the first post-operative visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive eccentric exercise 2x/week for an additional 8 weeks. For NMES, patients will have electrical stimulation delivered to their quadriceps. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For eccentric exercise, patients will train for 4 sets of 10 repetitions. This group will also receive standard of care ACL rehabilitation alongside the study interventions.
NMES placebo + ECC placebo
n=31 Participants
Neuromuscular electrical stimulation (NMES) low intensity/placebo + Eccentric Exercise (ECC) low intensity/placebo arm. Patients randomized to the NMES low intesntiy/placebo + ECC low intensity/placebo group will first receive NMES placebo/low-intensity treatment for 2x/week for 8 weeks, beginning at the first post-operative physical therapy visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive an eccentric exercise low-intensity/placebo 2x/week for 8 weeks. For the NMES low intensity/placebo, patients will have it delivered to their quadriceps 2x/week for 8 weeks beginning at the first post-operative visit. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For the eccentric exercise low-intensity/placebo, patients will begin to receive eccentric exercise two times per week for 8 weeks. Patients will train for 4 sets of 10 repetitions.
Knee Flexion Moment at 18 Months
1.5 Nm/kg*m
Standard Deviation 0.4
1.5 Nm/kg*m
Standard Deviation 0.3

SECONDARY outcome

Timeframe: 18 months post-ACL reconstruction

Population: Active High-Intensity NMES + ECC: 10 subjects withdrawn by investigator, 8 subjects lost to follow up, 2 subject withdrew consent, 1 person with MRI scan error so data is missing Placebo Low-Intensity NMES + ECC: 7 subjects withdrawn by investigator, 11 subjects lost to follow up, 2 subject withdrew consent

\[T1rho value at the weight bearing region of medial femur from MRI for ACL knee (msec)/T1rho value at the weight bearing region of medial femur for NonACL knee (msec)\] x 100

Outcome measures

Outcome measures
Measure
NMES+ECC
n=36 Participants
Neuromuscular electrical stimulation (NMES) and Eccentric Exercise (ECC). Patients randomized to the NMES+ECC group will first receive NMES for 2x/week for 8 weeks, beginning at the first post-operative visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive eccentric exercise 2x/week for an additional 8 weeks. For NMES, patients will have electrical stimulation delivered to their quadriceps. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For eccentric exercise, patients will train for 4 sets of 10 repetitions. This group will also receive standard of care ACL rehabilitation alongside the study interventions.
NMES placebo + ECC placebo
n=36 Participants
Neuromuscular electrical stimulation (NMES) low intensity/placebo + Eccentric Exercise (ECC) low intensity/placebo arm. Patients randomized to the NMES low intesntiy/placebo + ECC low intensity/placebo group will first receive NMES placebo/low-intensity treatment for 2x/week for 8 weeks, beginning at the first post-operative physical therapy visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive an eccentric exercise low-intensity/placebo 2x/week for 8 weeks. For the NMES low intensity/placebo, patients will have it delivered to their quadriceps 2x/week for 8 weeks beginning at the first post-operative visit. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For the eccentric exercise low-intensity/placebo, patients will begin to receive eccentric exercise two times per week for 8 weeks. Patients will train for 4 sets of 10 repetitions.
T1 Rho Relaxation Time Symmetry Score for Femoral Knee Joint Cartilage
103.0 Percentage
Standard Deviation 15.9
106.1 Percentage
Standard Deviation 21.9

SECONDARY outcome

Timeframe: 18 months post-ACL reconstruction

Population: NMES+ECC arm: 10 subjects withdrawn by investigator, 8 subjects lost to follow up, 2 subject withdrew consent, 1 person with MRI scan error so data is missing NMES placebo + ECC placebo arm: 7 subjects withdrawn by investigator, 11 subjects lost to follow up, 2 subject withdrew consent

\[T2 value from MRI at the central weight bearing region of femur for the ACL knee (msec)/T2 value from MRI at the central weight bearing region of femur for the NonACL knee (msec)\] x 100

Outcome measures

Outcome measures
Measure
NMES+ECC
n=36 Participants
Neuromuscular electrical stimulation (NMES) and Eccentric Exercise (ECC). Patients randomized to the NMES+ECC group will first receive NMES for 2x/week for 8 weeks, beginning at the first post-operative visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive eccentric exercise 2x/week for an additional 8 weeks. For NMES, patients will have electrical stimulation delivered to their quadriceps. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For eccentric exercise, patients will train for 4 sets of 10 repetitions. This group will also receive standard of care ACL rehabilitation alongside the study interventions.
NMES placebo + ECC placebo
n=36 Participants
Neuromuscular electrical stimulation (NMES) low intensity/placebo + Eccentric Exercise (ECC) low intensity/placebo arm. Patients randomized to the NMES low intesntiy/placebo + ECC low intensity/placebo group will first receive NMES placebo/low-intensity treatment for 2x/week for 8 weeks, beginning at the first post-operative physical therapy visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive an eccentric exercise low-intensity/placebo 2x/week for 8 weeks. For the NMES low intensity/placebo, patients will have it delivered to their quadriceps 2x/week for 8 weeks beginning at the first post-operative visit. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For the eccentric exercise low-intensity/placebo, patients will begin to receive eccentric exercise two times per week for 8 weeks. Patients will train for 4 sets of 10 repetitions.
T2 Relaxation Time Symmetry Score for Femoral Knee Joint Cartilage
101.3 Percentage
Standard Deviation 8.7
104.4 Percentage
Standard Deviation 9.8

Adverse Events

NMES+ECC

Serious events: 8 serious events
Other events: 2 other events
Deaths: 0 deaths

NMES Placebo + ECC Placebo

Serious events: 6 serious events
Other events: 3 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
NMES+ECC
n=57 participants at risk
Neuromuscular electrical stimulation (NMES) and Eccentric Exercise (ECC). Patients randomized to the NMES+ECC group will first receive NMES for 2x/week for 8 weeks, beginning at the first post-operative visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive eccentric exercise 2x/week for an additional 8 weeks. For NMES, patients will have electrical stimulation delivered to their quadriceps. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For eccentric exercise, patients will train for 4 sets of 10 repetitions. This group will also receive standard of care ACL rehabilitation alongside the study interventions.
NMES Placebo + ECC Placebo
n=56 participants at risk
Neuromuscular electrical stimulation (NMES) low intensity/placebo + Eccentric Exercise (ECC) low intensity/placebo arm. Patients randomized to the NMES low intesntiy/placebo + ECC low intensity/placebo group will first receive NMES placebo/low-intensity treatment for 2x/week for 8 weeks, beginning at the first post-operative physical therapy visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive an eccentric exercise low-intensity/placebo 2x/week for 8 weeks. For the NMES low intensity/placebo, patients will have it delivered to their quadriceps 2x/week for 8 weeks beginning at the first post-operative visit. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For the eccentric exercise low-intensity/placebo, patients will begin to receive eccentric exercise two times per week for 8 weeks. Patients will train for 4 sets of 10 repetitions.
Surgical and medical procedures
Appendectomy
1.8%
1/57 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
0.00%
0/56 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
Injury, poisoning and procedural complications
Accidental Overdose
1.8%
1/57 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
0.00%
0/56 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
Surgical and medical procedures
Septoplasty
0.00%
0/57 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
1.8%
1/56 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
Nervous system disorders
Loss of Consciousness
0.00%
0/57 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
1.8%
1/56 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
Respiratory, thoracic and mediastinal disorders
Hospitalization for severe persistent asthma w/ exacerbation
0.00%
0/57 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
1.8%
1/56 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
Surgical and medical procedures
Meniscal Surgery
5.3%
3/57 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
0.00%
0/56 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
Surgical and medical procedures
Cyclops lesion excision
1.8%
1/57 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
1.8%
1/56 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
Musculoskeletal and connective tissue disorders
Anterolateral Ligament Reconstruction with partial ACL graft tear
1.8%
1/57 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
0.00%
0/56 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
Musculoskeletal and connective tissue disorders
Contralateral ACL tear
1.8%
1/57 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
1.8%
1/56 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
Musculoskeletal and connective tissue disorders
Knee arthroscopy
0.00%
0/57 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
1.8%
1/56 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction

Other adverse events

Other adverse events
Measure
NMES+ECC
n=57 participants at risk
Neuromuscular electrical stimulation (NMES) and Eccentric Exercise (ECC). Patients randomized to the NMES+ECC group will first receive NMES for 2x/week for 8 weeks, beginning at the first post-operative visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive eccentric exercise 2x/week for an additional 8 weeks. For NMES, patients will have electrical stimulation delivered to their quadriceps. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For eccentric exercise, patients will train for 4 sets of 10 repetitions. This group will also receive standard of care ACL rehabilitation alongside the study interventions.
NMES Placebo + ECC Placebo
n=56 participants at risk
Neuromuscular electrical stimulation (NMES) low intensity/placebo + Eccentric Exercise (ECC) low intensity/placebo arm. Patients randomized to the NMES low intesntiy/placebo + ECC low intensity/placebo group will first receive NMES placebo/low-intensity treatment for 2x/week for 8 weeks, beginning at the first post-operative physical therapy visit. Beginning at 9 weeks after anterior cruciate ligament reconstruction (ACLR) patients will begin to receive an eccentric exercise low-intensity/placebo 2x/week for 8 weeks. For the NMES low intensity/placebo, patients will have it delivered to their quadriceps 2x/week for 8 weeks beginning at the first post-operative visit. Fifteen isometric actions lasting 10 seconds each will be elicited during each session. For the eccentric exercise low-intensity/placebo, patients will begin to receive eccentric exercise two times per week for 8 weeks. Patients will train for 4 sets of 10 repetitions.
Musculoskeletal and connective tissue disorders
ACL graft tear that was not reconstructed
3.5%
2/57 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction
5.4%
3/56 • From the time of study enrollment until the last study visit occurring at 18 months after ACL reconstruction

Additional Information

Riann Palmieri-Smith, PhD, ATC

University of Michigan

Phone: 734-615-3154

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place